OKYO Pharma
OKYO | NASDAQ
$1.18
-$0.17 (-12.59%)
At close: Nov 16, 2026, 4:00 PM ET
$1.18
$0.00 (-0.42%)
After-hours:
Nov 16, 2026, 4:26 PM ET
-12.59%
(1D)No price chart data available for 1D timeframe.
Rating
25.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #919/1021 (Top 90%)
Key Statistics
Market Data
Market Cap $61.66M
1D Range
1.15 1.35
52W Range
1.15 3.11
Valuation (TTM)
PE -4.92
PB 5.00
EV/EBITDA -4.46
Valuation (NTM)
Forward PE N/A
Forward PEG -0.16
Price Target $5.00
Cash Flow
FCF Yield -9.6%
SBC Adj. FCF Yield -9.6%
SBC Impact N/A
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 30.0% |
-19.9%
FCF 3Y | 5Y -4.3% |
-41.5%
Returns
ROA -42.7%
ROE -200.7%
ROIC -74.6%
Financial Health
Net Cash
$20.59M
Current Ratio 2.43
Interest Coverage -20.81
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
OKYO Pharma Limited is a biopharmaceutical firm operating at the preclinical stage, dedicated to developing innovative treatments for individuals in the United Kingdom experiencing inflammatory eye co...
Sector Healthcare
Industry Biotechnology
Employees 5
IPO Date May 17, 2022
Website www.okyopharma.com
Fiscal Year April - March
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$5.00
Upside
+323.73%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove OKYO